Media

Vicore publishes the Annual Report for 2025

Intervacc announces breakthrough protection against Streptococcus suis infection in piglets

Aro Biotherapeutics Reports Positive Phase 1b Topline Results for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD)

Outcome in Oncopeptides’ rights issue 

Oncopeptides initiates MARINA study to strengthen real-world evidence for Pepaxti in Germany

Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Oncopeptides – European Journal of Haematology: Real-World Data reinforces Pepaxti’s role in treatment sequencing for multiple myeloma

Positrigo Reaches Final of the Swiss Medtech Award 2026

First patient dosed in Gesynta Pharma’s endometriosis trial of vipoglanstat

Pretzel Therapeutics Presents Preclinical Data on PX578 at MDA 2026, Further Supporting Clinical Advancement in Individuals Living with POLG Disease